Abbott Laboratories Earnings Estimate

ABT
 Stock
  

USD 111.48  0.99  0.90%   

Many public companies, such as Abbott Laboratories, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Abbott Laboratories' earnings estimates, investors can diagnose different trends across Abbott Laboratories' analyst sentiment over time as well as compare current estimates against different timeframes.
Abbott Laboratories is projected to generate 5.06 in earnings per share on the 31st of December 2021. Abbott Laboratories earnings estimates module stress-tests analyst consensus about projected Abbott Laboratories EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Please continue to Trending Equities.
  
Gross Profit is likely to drop to about 21.4 B in 2022. Profit Margin is likely to drop to 0.14 in 2022

Abbott Laboratories Earnings Estimation Breakdown

Calculation of earning per share of Abbott Laboratories is based on official Zacks consensus of 6 analysts regarding Abbott Laboratories future annual earnings. Given the historical accuracy of 95.92%, the future earnings per share of Abbott Laboratories is estimated to be 5.06 with the lowest and highest values of 5.04 and 5.1, respectively. Please note that this consensus of annual earnings estimates for Abbott Laboratories is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS 4.03
5.04
Lowest
Expected EPS 5.06
5.10
Highest

Abbott Laboratories Earnings Projection Consensus

Suppose the current estimates of Abbott Laboratories' value are higher than the current market price of the Abbott Laboratories stock. In this case, investors may conclude that Abbott Laboratories is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Abbott Laboratories' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

6

95.92%

4.03

5.06

Abbott Laboratories Earnings History

Earnings estimate consensus by Abbott Laboratories analysts from Wall Street is used by the market to judge Abbott Laboratories' stock performance. The investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Abbott Laboratories' upcoming profit reports and earnings-per-share forecasts but also compare them to our different valuation methods.

Abbott Laboratories Quarterly Earnings Before Interest Taxes and Depreciation Amortization EBITDA

3.31 Billion

Abbott Laboratories Earnings per Basic Share are comparatively stable at the moment as compared to the past year. Abbott Laboratories reported Earnings per Basic Share of 3.97 in 2021. Earnings per Diluted Share is likely to gain to 4.25 in 2022, whereas Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop slightly above 10.6 B in 2022. Abbott Laboratories Weighted Average Shares is comparatively stable at the moment as compared to the past year. Abbott Laboratories reported Weighted Average Shares of 1.77 Billion in 2021. Weighted Average Shares Diluted is likely to gain to about 1.9 B in 2022, whereas Issuance Purchase of Equity Shares is likely to drop (2.1 B) in 2022.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Abbott Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Abbott Laboratories in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
109.89111.48113.07
Details
Intrinsic
Valuation
LowReal ValueHigh
100.33125.36126.95
Details
Naive
Forecast
LowNext ValueHigh
111.07112.66114.26
Details
14 Analysts
Consensus
LowTarget PriceHigh
125.00140.33157.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Abbott Laboratories. Your research has to be compared to or analyzed against Abbott Laboratories' peers to derive any actionable benefits. When done correctly, Abbott Laboratories' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Abbott Laboratories.
Note that many institutional investors and large investment bankers can move markets due to the volume of Abbott assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Abbott Laboratories. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Abbott stock price in the short term.

Abbott Laboratories Earnings per Share Projection vs Actual

Actual Earning per Share of Abbott Laboratories refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Abbott Laboratories predict the company's earnings will be in the future. The higher the earnings per share of Abbott Laboratories, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Abbott Laboratories Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Abbott Laboratories, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Abbott Laboratories should always be considered in relation to other companies to make a more educated investment decision.

Abbott Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Abbott Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-07-20
2022-06-301.131.430.326 
2022-04-20
2022-03-311.471.730.2617 
2022-01-26
2021-12-311.211.320.11
2021-10-20
2021-09-300.951.40.4547 
2021-07-22
2021-06-301.021.170.1514 
2021-04-20
2021-03-311.271.320.05
2021-01-27
2020-12-311.351.450.1
2020-10-21
2020-09-300.910.980.07
2020-07-16
2020-06-300.420.570.1535 
2020-04-16
2020-03-310.580.650.0712 
2020-01-22
2019-12-310.950.950
2019-10-16
2019-09-300.840.840
2019-07-17
2019-06-300.80.820.02
2019-04-17
2019-03-310.610.630.02
2019-01-23
2018-12-310.810.810
2018-10-17
2018-09-300.750.750
2018-07-18
2018-06-300.710.730.02
2018-04-18
2018-03-310.580.590.01
2018-01-24
2017-12-310.730.740.01
2017-10-18
2017-09-300.650.660.01
2017-07-20
2017-06-300.610.620.01
2017-04-19
2017-03-310.430.480.0511 
2017-01-25
2016-12-310.650.650
2016-10-19
2016-09-300.580.590.01
2016-07-20
2016-06-300.530.550.02
2016-04-20
2016-03-310.390.410.02
2016-01-28
2015-12-310.610.620.01
2015-10-21
2015-09-300.530.540.01
2015-07-22
2015-06-300.50.520.02
2015-04-22
2015-03-310.420.470.0511 
2015-01-29
2014-12-310.680.710.03
2014-10-22
2014-09-300.590.620.03
2014-07-16
2014-06-300.510.540.03
2014-04-16
2014-03-310.360.410.0513 
2014-01-22
2013-12-310.580.580
2013-10-16
2013-09-300.510.550.04
2013-07-17
2013-06-300.440.460.02
2013-04-17
2013-03-310.410.420.01
2013-01-23
2012-12-311.51.510.01
2012-10-17
2012-09-301.281.30.02
2012-07-18
2012-06-301.221.230.01
2012-04-18
2012-03-3111.030.03
2012-01-25
2011-12-311.441.450.01
2011-10-19
2011-09-301.171.180.01
2011-07-20
2011-06-301.111.120.01
2011-04-20
2011-03-310.90.910.01
2011-01-26
2010-12-311.291.30.01
2010-10-20
2010-09-301.041.050.01
2010-07-21
2010-06-3011.010.01
2010-04-21
2010-03-310.80.810.01
2010-01-27
2009-12-311.171.180.01
2009-10-14
2009-09-300.90.920.02
2009-07-15
2009-06-300.890.890
2009-04-15
2009-03-310.70.730.03
2009-01-21
2008-12-311.061.060
2008-10-15
2008-09-300.770.790.02
2008-07-16
2008-06-300.790.840.05
2008-04-16
2008-03-310.620.630.01
2008-01-23
2007-12-310.920.930.01
2007-10-17
2007-09-300.660.670.01
2007-07-18
2007-06-300.680.690.01
2007-04-18
2007-03-310.520.550.03
2007-01-24
2006-12-310.740.750.01
2006-10-18
2006-09-300.580.580
2006-07-19
2006-06-300.570.620.05
2006-04-19
2006-03-310.570.570
2006-01-25
2005-12-310.760.760
2005-10-19
2005-09-300.580.580
2005-07-13
2005-06-300.570.580.01
2005-04-12
2005-03-310.580.580
2005-01-18
2004-12-310.670.670
2004-10-14
2004-09-300.530.530
2004-07-09
2004-06-300.540.540
2004-04-08
2004-03-310.560.570.01
2004-01-16
2003-12-310.650.650
2003-10-09
2003-09-300.530.530
2003-07-10
2003-06-300.520.520
2003-04-09
2003-03-310.510.510
2003-01-16
2002-12-310.560.55-0.01
2002-10-09
2002-09-300.480.480
2002-07-11
2002-06-300.490.490
2002-04-09
2002-03-310.540.540
2002-01-16
2001-12-310.520.520
2001-10-10
2001-09-300.440.440
2001-07-12
2001-06-300.450.450
2001-04-12
2001-03-310.470.470
2001-01-16
2000-12-310.480.480
2000-10-10
2000-09-300.420.420
2000-07-12
2000-06-300.440.440
2000-04-11
2000-03-310.440.440
2000-01-18
1999-12-310.430.430
1999-10-11
1999-09-300.380.380
1999-07-09
1999-06-300.420.420
1999-04-08
1999-03-310.430.440.01
1999-01-15
1998-12-310.410.410
1998-10-08
1998-09-300.340.340
1998-07-09
1998-06-300.370.380.01
1998-04-09
1998-03-310.380.380
1998-01-16
1997-12-310.370.370
1997-10-08
1997-09-300.310.310
1997-07-10
1997-06-300.340.340
1997-04-09
1997-03-310.340.350.01
1997-01-16
1996-12-310.330.330
1996-10-08
1996-09-300.270.270
1996-07-10
1996-06-300.30.30
1996-04-08
1996-03-310.290.310.02

About Abbott Laboratories Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Abbott Laboratories earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Abbott Laboratories estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Abbott Laboratories fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Accumulated Retained Earnings Deficit31.5 B31.1 B
Earning Before Interest and Taxes EBIT8.7 B7.3 B
Earnings per Basic Share 3.97  4.28 
Earnings per Diluted Share 3.94  4.25 
Price to Earnings Ratio 35.45  46.64 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA12.3 B10.6 B
Earnings before Tax8.2 B6.7 B
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people.

Abbott Laboratories Investors Sentiment

The influence of Abbott Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abbott. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Abbott Laboratories' public news can be used to forecast risks associated with investment in Abbott. The trend in average sentiment can be used to explain how an investor holding Abbott can time the market purely based on public headlines and social activities around Abbott Laboratories. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Abbott Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abbott Laboratories' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Abbott Laboratories' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Abbott Laboratories.

Abbott Laboratories Implied Volatility

    
  22.06  
Abbott Laboratories' implied volatility exposes the market's sentiment of Abbott Laboratories stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abbott Laboratories' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abbott Laboratories stock will not fluctuate a lot when Abbott Laboratories' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abbott Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abbott Laboratories' short interest history, or implied volatility extrapolated from Abbott Laboratories options trading.

Pair Trading with Abbott Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.73
Market Capitalization
193.5 B
Quarterly Revenue Growth YOY
0.1
Return On Assets
0.0896
Return On Equity
0.24
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.